EIT Health

EIT Health
Name	EIT Health
Type	Public-private partnership
Founded	2015
Headquarters	Paris, Berlin, Munich
Region	Europe
CEO	Unknown

EIT Health is a European health innovation community that supports biomedical innovation, entrepreneurship, and healthcare delivery across the European Union, United Kingdom, and associated states. The organization builds links among universities, research institutes, hospitals, insurers, and corporations to accelerate development of biomedical products, digital health solutions, and health services. It operates through regional hubs and thematic programs to translate research into market-ready technologies and scaled services.

History

EIT Health originated from the European Institute of Innovation and Technology initiative to strengthen innovation ecosystems across the European Union and was launched in 2015 alongside contemporaries supported by the Horizon 2020 framework. Early milestones involved partnerships with leading European universities such as Karolinska Institutet, Imperial College London, École Polytechnique Fédérale de Lausanne, and Technical University of Munich, and collaborations with healthcare providers including Karolinska University Hospital and Charité – Universitätsmedizin Berlin. The organization expanded during successive European research funding cycles tied to Horizon Europe and coordinated with entities like the European Commission, European Medicines Agency, and national innovation agencies in France, Germany, Spain, and Italy. Key phases included the establishment of regional hubs in cities like Paris, Berlin, Munich, London, Madrid, and Milan and the rollout of education and accelerator programs in partnership with business schools such as INSEAD and HEC Paris.

Organization and Governance

Governance structures combine representatives from academic institutions, industry consortia, and healthcare providers. The executive management reports to a board composed of members from partners such as Novartis, Sanofi, Siemens Healthineers, Philips, and large payer organizations. Advisory groups include clinical leaders from Guy's and St Thomas' NHS Foundation Trust, regulatory experts linked to the European Medicines Agency, and investor representatives from venture capital firms like Atomico and Index Ventures. Corporate partners coordinate with academic partners including University College London, ETH Zurich, and University of Cambridge alongside research institutes such as Max Planck Society and CNRS. National contact points link the community to ministries in France, Germany, Spain, Italy, and other member states.

Programs and Initiatives

Programs span entrepreneurship, education, and innovation support. Accelerator cohorts collaborate with startups including medtech firms or digital therapeutics ventures associated with incubators like Station F and NHS Innovation Accelerator. Education initiatives are delivered with partners such as IE Business School, ESADE, and Imperial College Business School and include masterclasses, summer schools, and executive courses. Innovation projects fund translational research in areas overlapping with institutes like Karolinska Institutet, Delft University of Technology, and Politecnico di Milano and focus on domains including precision medicine, digital health platforms, medical devices, and ageing care with stakeholders such as AstraZeneca and Roche. Pilot deployments and scale-up pathways have been tested in city health systems including Stockholm, Barcelona, Munich, and London.

Partnerships and Network

The network comprises over a hundred core partners drawn from universities, hospitals, research organizations, industry, and investors. Academic partners include University of Oxford, University of Cambridge, Maastricht University, Trinity College Dublin, and Sorbonne University; hospital partners include Azienda Ospedaliero-Universitaria, Charité – Universitätsmedizin Berlin, and Hôpital Pitié-Salpêtrière. Corporate alliances feature multinational firms such as Philips, Siemens Healthineers, BD (Becton, Dickinson and Company), and GE Healthcare. Collaborations extend to innovation intermediaries like Nesta, incubators such as EIT Digital Accelerator peers, and funding bodies including European Investment Bank and national development agencies. Cross-border projects have linked metropolitan clusters including Île-de-France, Bavaria, Catalonia, and Lombardy.

Funding and Financial Structure

Funding is a mix of grants, partner contributions, and co-investments. Core financing originated from the European Institute of Innovation and Technology as part of the Horizon 2020 budget lines, later supplemented through Horizon Europe allocations and co-funding by industry partners like Sanofi and Novartis. Additional revenue streams include fees for executive education with business schools such as INSEAD and IE Business School, accelerator equity stakes taken alongside venture capital co-investors including Balderton Capital and Atomico, and public grants from national agencies in Germany, France, and Spain. Financial oversight is exercised by an audit committee and external auditors drawn from the Big Four network and regional accounting firms.

Impact and Outcomes

Measured outcomes include the creation and scaling of startups, licensing deals, deployed digital health services, and trained health entrepreneurs and clinicians. Portfolio companies and alumni have attracted follow-on capital from investors such as Index Ventures, Sequoia Capital, and Accel Partners, and have reached procurement agreements with health systems like the NHS and hospital networks in Germany and France. Education programs report participants from institutions including Karolinska Institutet, Imperial College London, and ETH Zurich who have advanced into leadership roles across firms such as Roche and Philips. Notable impacts include pilot deployments in ageing care in Madrid and telemedicine rollouts in Sweden; peer-reviewed collaborations have involved journals and research groups linked to Lancet-affiliated networks and academic consortia. Ongoing evaluations assess health-system adoption, cost-effectiveness, and scaling potential in coordination with agencies like the European Investment Bank and regional health authorities.

Category:European health organizations